Initial Emergency Department Diagnosis and Management of Adult Patients with Severe Sepsis and Septic Shock

Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine

Volumn 20, Issue , 2012, Pages

  Perman, Sarah M ^a   Goyal, Munish ^b   Gaieski, David F ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Early goal directed therapy; Resuscitation; Sepsis; Septic shock

Indexed keywords

ANTIINFECTIVE AGENT; CARDIOTONIC AGENT; VASOCONSTRICTOR AGENT;

ADULT; DRUG EFFECT; EMERGENCY HEALTH SERVICE; FLUID THERAPY; HEMODYNAMICS; HUMAN; METHODOLOGY; MULTIMODALITY CANCER THERAPY; ORGANIZATION AND MANAGEMENT; PATHOPHYSIOLOGY; PHYSIOLOGY; PRACTICE GUIDELINE; REVIEW; SEPSIS; SEPTIC SHOCK; SEVERITY OF ILLNESS INDEX; STANDARD; SURVIVAL RATE; TIME;

ADULT; ANTI-BACTERIAL AGENTS; CARDIOTONIC AGENTS; COMBINED MODALITY THERAPY; EMERGENCY SERVICE, HOSPITAL; FLUID THERAPY; HEMODYNAMICS; HUMANS; PRACTICE GUIDELINES AS TOPIC; SEPSIS; SEVERITY OF ILLNESS INDEX; SHOCK, SEPTIC; SURVIVAL RATE; TIME FACTORS; TRIAGE; VASOCONSTRICTOR AGENTS;

EID: 84862727670     PISSN: None     EISSN: 17577241     Source Type: Journal    
DOI: 10.1186/1757-7241-20-41     Document Type: Review

References (54)

1. Slade E, Tamber PS, Vincent J-L. The Surviving Sepsis Campaign: raising awareness to reduce mortality. Critical Care. 2003, 7(1):1. 10.1186/cc1876, 154124, 12617727.
2. Angus DC, Linde-Zwirble WT, Lidicker J, et al. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit. Care Med. 2001, 29(7):1303-1310. 10.1097/00003246-200107000-00002, 11445675.
3. Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest. 1992, 101(6):1644-1655.
4. Wang HE, Shapiro NI, Angus DC, Yealy DM. National estimates of severe sepsis in United States emergency departments. Crit. Care Med. 2007, 35(8):1928-1936. 10.1097/01.CCM.0000277043.85378.C1, 17581480.
5. Kumar A, Roberts D. Wood KE, et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit. Care Med. 2006, 34(6):1589-1596.
6. Rivers E, Nguyen B, Havstad S, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N. Engl. J. Med. 2001, 345(19):1368-1377. 10.1056/NEJMoa010307, 11794169.
7. Green RS, MacIntyre JK. Critical Care in the Emergency Department: An assessment of the length of stay and invasive procedures performed on critically ill ED patients. Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine 2009, 17(1):47. 10.1186/1757-7241-17-47, 2761844, 19778429.
8. Anon R. Practice parameters for hemodynamic support of sepsis in adult patients in sepsis. Task Force of the American College of Critical Care Medicine, Society of Critical Care Medicine. Crit. Care Med 1999, 27(3):639-660. 10.1097/00003246-199903000-00049, 10199548.
9. Dellinger RP, Carlet JM, Masur H, et al. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit. Care Med. 2004, 32(3):858-873. 10.1097/01.CCM.0000117317.18092.E4, 15090974.
10. Dellinger RP, Levy MM, Carlet JM, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit. Care Med. 2008, 36(1):296-327. 10.1097/01.CCM.0000298158.12101.41, 18158437.
11. Ferrer R, Artigas A, Levy MM, et al. Improvement in process of care and outcome after a multicenter severe sepsis educational program in Spain. JAMA. 2008, 299(19):2294-2303. 10.1001/jama.299.19.2294, 18492971.
12. Rubulotta FM, Ramsay G, Parker MM, et al. An international survey: Public awareness and perception of sepsis. Crit. Care Med. 2009, 37(1):167-170. 10.1097/CCM.0b013e3181926883, 19123265.
13. Levy MM, Dellinger RP, Townsend SR, et al. The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsis. Crit. Care Med. 2010, 38(2):367-374. 10.1097/CCM.0b013e3181cb0cdc, 20035219.
14. Cinel I. Dellinger RP. Advances in pathogenesis and management of sepsis. Curr. Opin. Infect. Dis. 2007, 20(4):345-352.
15. Bone RC, Grodzin CJ, Balk RA. Sepsis: a new hypothesis for pathogenesis of the disease process. Chest. 1997, 112(1):235-243. 10.1378/chest.112.1.235, 9228382.
16. De Backer D, Creteur J. Preiser J-C, Dubois M-J. Vincent J-L. Microvascular Blood Flow Is Altered in Patients with Sepsis. Am. J. Respir. Crit. Care Med. 2002, 166(1):98-104.
17. Comstedt P, Storgaard M, Lassen AT. The Systemic Inflammatory Response Syndrome (SIRS) in acutely hospitalised medical patients: a cohort study. Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine 2009, 17(1):67. 10.1186/1757-7241-17-67, 2806258, 20035633.
18. Shapiro N, Howell MD, Bates DW, et al. The association of sepsis syndrome and organ dysfunction with mortality in emergency department patients with suspected infection. Ann Emerg Med 2006, 48(5):583-590. 590.e1, 10.1016/j.annemergmed.2006.07.007, 17052559.
19. Revelly J-P, Tappy L, Martinez A, et al. Lactate and glucose metabolism in severe sepsis and cardiogenic shock. Crit. Care Med. 2005, 33(10):2235-2240. 10.1097/01.CCM.0000181525.99295.8F, 16215376.
20. Shapiro NI, Howell MD, Talmor D, et al. Serum lactate as a predictor of mortality in emergency department patients with infection. Ann Emerg Med. 2005, 45(5):524-528. 10.1016/j.annemergmed.2004.12.006, 15855951.
21. Mikkelsen ME, Miltiades AN, Gaieski DF, et al. Serum lactate is associated with mortality in severe sepsis independent of organ failure and shock. Crit. Care Med. 2009, 37(5):1670-1677. 10.1097/CCM.0b013e31819fcf68, 19325467.
22. Broder G, Weil MH. EXCESS LACTATE: AN INDEX OF REVERSIBILITY OF SHOCK IN HUMAN PATIENTS. Science. 1964, 143(3613):1457-1459. 10.1126/science.143.3613.1457, 14107454.
23. Aduen J, Bernstein WK, Khastgir T, et al. The use and clinical importance of a substrate-specific electrode for rapid determination of blood lactate concentrations. JAMA. 1994, 272(21):1678-1685. 10.1001/jama.1994.03520210062033, 7966896.
24. Shapiro NI, Wolfe RE, Moore RB, et al. Mortality in Emergency Department Sepsis (MEDS) score: a prospectively derived and validated clinical prediction rule. Crit. Care Med. 2003, 31(3):670-675. 10.1097/01.CCM.0000054867.01688.D1, 12626967.
25. Jones AE, Saak K, Kline JA. Performance of the Mortality in Emergency Department Sepsis score for predicting hospital mortality among patients with severe sepsis and septic shock. Am J Emerg Med. 2008, 26(6):689-692. 10.1016/j.ajem.2008.01.009, 2713792, 18606322.
26. Jones AE, Trzeciak S, Kline JA. The Sequential Organ Failure Assessment score for predicting outcome in patients with severe sepsis and evidence of hypoperfusion at the time of emergency department presentation. Crit. Care Med. 2009, 37(5):1649-1654. 10.1097/CCM.0b013e31819def97, 2703722, 19325482.
27. Otero RM, Nguyen HB, Huang DT, et al. Early goal-directed therapy in severe sepsis and septic shock revisited: concepts, controversies, and contemporary findings. Chest. 2006, 130(5):1579-1595. 10.1378/chest.130.5.1579, 17099041.
28. Marik PE, Monnet X, Teboul J-L. Hemodynamic parameters to guide fluid therapy. Ann Intensive Care 2011, 1(1):1. 10.1186/2110-5820-1-1, 3159904, 21906322.
29. Boyd JH, Forbes J, Nakada T, Walley KR, Russell JA. Fluid resuscitation in septic shock: a positive fluid balance and elevated central venous pressure are associated with increased mortality. Crit. Care Med. 2011, 39(2):259-265. 10.1097/CCM.0b013e3181feeb15, 20975548.
30. Murphy CV, Schramm GE, Doherty JA, et al. The Importance of Fluid Management in Acute Lung Injury Secondary to Septic Shock. Chest. 2009, 136(1):102-109. 10.1378/chest.08-2706, 19318675.
31. Varpula M, Tallgren M, Saukkonen K, Voipio-Pulkki L-M, Pettilä V. Hemodynamic variables related to outcome in septic shock. Intensive Care Med. 2005, 31(8):1066-1071. 10.1007/s00134-005-2688-z, 15973520.
32. LeDoux D. Astiz ME, Carpati CM. Rackow EC. Effects of perfusion pressure on tissue perfusion in septic shock. Crit. Care Med. 2000, 28(8):2729-2732.
33. Boerma EC, Ince C. The role of vasoactive agents in the resuscitation of microvascular perfusion and tissue oxygenation in critically ill patients. Intensive Care Med. 2010, 36(12):2004-2018. 10.1007/s00134-010-1970-x, 2981743, 20811874.
34. Thooft A, Favory R, Salgado D, et al. Effects of changes in arterial pressure on organ perfusion during septic shock. Critical Care. 2011, 15(5):R222. 10.1186/cc10462, 3334768, 21936903.
35. Ladakis C, Myrianthefs P, Karabinis A, et al. Central venous and mixed venous oxygen saturation in critically ill patients. Respiration. 2001, 68(3):279-285. 10.1159/000050511, 11416249.
36. Mozina H, Podbregar M. Near-infrared spectroscopy during stagnant ischemia estimates central venous oxygen saturation and mixed venous oxygen saturation discrepancy in patients with severe left heart failure and additional sepsis/septic shock. Crit Care. 2010, 14(2):R42. 10.1186/cc8929, 2887154, 20331856.
37. Pope JV, Jones AE, Gaieski DF, et al. Multicenter study of central venous oxygen saturation (ScvO(2)) as a predictor of mortality in patients with sepsis. Ann Emerg Med 2010, 55(1):40-46. 10.1016/j.annemergmed.2009.08.014, 2828585, 19854541.
38. Nguyen HB, Rivers EP, Knoblich BP, et al. Early lactate clearance is associated with improved outcome in severe sepsis and septic shock. Crit. Care Med. 2004, 32(8):1637-1642. 10.1097/01.CCM.0000132904.35713.A7, 15286537.
39. Jones AE, Shapiro NI, Trzeciak S, et al. Lactate clearance vs central venous oxygen saturation as goals of early sepsis therapy: a randomized clinical trial. JAMA. 2010, 303(8):739-746. 10.1001/jama.2010.158, 2918907, 20179283.
40. Rivers EP, Elkin R, Cannon CM. Counterpoint: should lactate clearance be substituted for central venous oxygen saturation as goals of early severe sepsis and septic shock therapy?. No. Chest 2011, 140(6):1408-1413. discussion 1413-1419.
41. Nagdev AD, Merchant RC, Tirado-Gonzalez A, Sisson CA, Murphy MC. Emergency department bedside ultrasonographic measurement of the caval index for noninvasive determination of low central venous pressure. Ann Emerg Med. 2010, 55(3):290-295. 10.1016/j.annemergmed.2009.04.021, 19556029.
42. Napoli AM, Machan JT, Corl K, Forcada A. The use of impedance cardiography in predicting mortality in emergency department patients with severe sepsis and septic shock. AcadEmerg Med 2010, 17(4):452-455.
43. Napoli AM, Machan JT, Forcada A, Corl K, Gardiner F. Tissue Oxygenation Does Not Predict Central Venous Oxygenation in Emergency Department Patients With Severe Sepsis and Septic Shock. Academic Emergency Medicine. 2010, 17(4):349-352.
44. De Backer D, Biston P, Devriendt J, et al. Comparison of dopamine and norepinephrine in the treatment of shock. N. Engl. J. Med. 2010, 362(9):779-789. 10.1056/NEJMoa0907118, 20200382.
45. Russell JA, Walley KR, Singer J, et al. Vasopressin versus norepinephrine infusion in patients with septic shock. N. Engl. J. Med. 2008, 358(9):877-887. 10.1056/NEJMoa067373, 18305265.
46. van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in the critically ill patients. N. Engl. J. Med. 2001, 345(19):1359-1367. 10.1056/NEJMoa011300, 11794168.
47. Wiener RS, Wiener DC, Larson RJ. Benefits and risks of tight glucose control in critically ill adults: a meta-analysis. JAMA. 2008, 300(8):933-944. 10.1001/jama.300.8.933, 18728267.
48. Annane D, Sébille V, Charpentier C, et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA. 2002, 288(7):862-871. 10.1001/jama.288.7.862, 12186604.
49. Sprung CL, Annane D, Keh D, et al. Hydrocortisone therapy for patients with septic shock. N. Engl. J. Med. 2008, 358(2):111-124. 10.1056/NEJMoa071366, 18184957.
50. Moreno R, Sprung CL, Annane D, et al. Time course of organ failure in patients with septic shock treated with hydrocortisone: results of the Corticus study. Intensive Care Med. 2011, 37(11):1765-1772. 10.1007/s00134-011-2334-x, 21847649.
51. Fuller BM, Gajera M, Schorr C, et al. Transfusion of Packed Red Blood Cells is Not Associated with Improved Central Venous Oxygen Saturation or Organ Function in Patients with Septic Shock. The Journal of Emergency Medicine 2012, : . http://proxy.library.upenn.edu:2135/science/article/pii/S0736467912001278.
52. Gaieski DF, Mikkelsen ME, Band RA, et al. Impact of time to antibiotics on survival in patients with severe sepsis or septic shock in whom early goal-directed therapy was initiated in the emergency department. Crit. Care Med. 2010, 38(4):1045-1053. 10.1097/CCM.0b013e3181cc4824, 20048677.
53. Puskarich MA, Trzeciak S, Shapiro NI, et al. Association between timing of antibiotic administration and mortality from septic shock in patients treated with a quantitative resuscitation protocol. Crit. Care Med. 2011, 39(9):2066-2071. 10.1097/CCM.0b013e31821e87ab, 3158284, 21572327.
54. Karlsson S, Varpula M, Ruokonen E, et al. Incidence, treatment, and outcome of severe sepsis in ICU-treated adults in Finland: the Finnsepsis study. Intensive Care Medicine. 2007, 33(3):435-443. 10.1007/s00134-006-0504-z, 17225161.